---
title: "This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289082529.md"
description: "Wall Street analysts downgraded two stocks: HC Wainwright & Co. lowered ADC Therapeutics (ADCT) from Buy to Neutral, while Wells Fargo cut W. R. Berkley (WRB) from Equal-Weight to Underweight and reduced its price target to $58."
datetime: "2026-06-08T16:13:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289082529.md)
  - [en](https://longbridge.com/en/news/289082529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289082529.md)
---

# This ADC Therapeutics Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   HC Wainwright & Co. analyst Robert Burns downgraded **ADC Therapeutics SA** (NYSE:ADCT) from Buy to Neutral. ADC Therapeutics shares closed at $1.0250 on Friday. See how other analysts view this stock.
-   Wells Fargo analyst Elyse Greenspan downgraded **W. R. Berkley Corporation** (NYSE:WRB) from Equal-Weight to Underweight and lowered the price target from $64 to $58. WR Berkley shares closed at $68.57 on Friday. See how other analysts view this stock.

Considering buying ADCT stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [ADCT.US](https://longbridge.com/en/quote/ADCT.US.md)
- [WRB.US](https://longbridge.com/en/quote/WRB.US.md)
- [WRB-G.US](https://longbridge.com/en/quote/WRB-G.US.md)
- [WRB-E.US](https://longbridge.com/en/quote/WRB-E.US.md)
- [WRB-H.US](https://longbridge.com/en/quote/WRB-H.US.md)
- [WRB-F.US](https://longbridge.com/en/quote/WRB-F.US.md)

## Related News & Research

- [W. R. Berkley Corporation Announces the Passing of Its Founder and Executive Chairman, William R. Berkley | WRB Stock News](https://longbridge.com/en/news/289243600.md)
- [W. R. Berkley Raised Its Dividend by Over 11%, But Don’t Rush to Buy WRB Stock Here](https://longbridge.com/en/news/289111473.md)
- [ADC Therapeutics reports positive LOTIS-5 PFS results; plans pre-sBLA meeting and Q4 2026 sBLA](https://longbridge.com/en/news/288624565.md)
- [Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile](https://longbridge.com/en/news/289475996.md)
- [Pinebridge Investments LLC Makes New $1.13 Million Investment in W.R. Berkley Corporation $WRB](https://longbridge.com/en/news/289164687.md)